DE60014936D1 - Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel - Google Patents

Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel

Info

Publication number
DE60014936D1
DE60014936D1 DE2000614936 DE60014936T DE60014936D1 DE 60014936 D1 DE60014936 D1 DE 60014936D1 DE 2000614936 DE2000614936 DE 2000614936 DE 60014936 T DE60014936 T DE 60014936T DE 60014936 D1 DE60014936 D1 DE 60014936D1
Authority
DE
Germany
Prior art keywords
ring
further substituted
dihydrobenzofuranes
tricyclic
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE2000614936
Other languages
English (en)
Other versions
DE60014936T2 (de
Inventor
Shigenori Ohkawa
Tadatoshi Hashimoto
Tetsuya Tsukamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE60014936D1 publication Critical patent/DE60014936D1/de
Publication of DE60014936T2 publication Critical patent/DE60014936T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60014936T 1999-08-20 2000-08-18 Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel Expired - Lifetime DE60014936T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23471899 1999-08-20
JP23471899 1999-08-20
PCT/JP2000/005523 WO2001014384A1 (fr) 1999-08-20 2000-08-18 Derives dihydrobenzofuran tricycliques, leur procede de preparation et agents

Publications (2)

Publication Number Publication Date
DE60014936D1 true DE60014936D1 (de) 2004-11-18
DE60014936T2 DE60014936T2 (de) 2005-10-13

Family

ID=16975297

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60014936T Expired - Lifetime DE60014936T2 (de) 1999-08-20 2000-08-18 Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel

Country Status (7)

Country Link
US (1) US6872718B1 (de)
EP (1) EP1211253B1 (de)
AT (1) ATE279191T1 (de)
AU (1) AU6594900A (de)
CA (1) CA2382413A1 (de)
DE (1) DE60014936T2 (de)
WO (1) WO2001014384A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2382418A1 (en) 1999-08-20 2001-03-01 Shigenori Ohkawa Dihydrobenzofuran derivatives, process for preparing thereof and agents
US7728155B2 (en) * 2003-10-24 2010-06-01 Wyeth Llc Dihydrobenzofuranyl alkanamines and methods for using same as cns agents
CN100448861C (zh) * 2003-10-24 2009-01-07 惠氏公司 二氢苯并呋喃烷胺和含有它们的药物组合物
US7435837B2 (en) 2003-10-24 2008-10-14 Wyeth Dihydrobenzofuranyl alkanamine derivatives and methods for using same
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20080045725A1 (en) 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
EP2262508B1 (de) * 2008-03-05 2018-10-03 BioElectron Technology Corporation SUBSTITUIERTE p-CHINONDERIVATE ZUR BEHANDLUNG VON ERKRANKUNGEN IN VERBINDUNG MIT OXIDATIVEM STRESS
EP2462165B1 (de) 2009-08-03 2016-05-11 University of Miami Verfahren zur in-vivo-expansion regulatorischer t-zellen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2030899A1 (de) 1970-06-18 1971-12-23 Schering Ag, 1000 Berlin Und 4619 Bergkamen Chinolincarbonsäurederivate
US4008237A (en) 1972-07-14 1977-02-15 Sumitomo Chemical Company, Limited 2,3,5,8-Tetrahydro-5-alkoxy-8-oxofuro(2,3-g)quinoline-7-carboxylic acid derivatives
JPS50117908A (de) 1974-02-27 1975-09-16
JPS50117909A (de) 1974-02-27 1975-09-16
GB1556747A (en) 1976-07-05 1979-11-28 Schering Ag 8-oxo-2 3 5 8-tetrahydrofuro 2 3-g quincline-7- carboxylicacid derivatives
JP2855340B2 (ja) * 1988-06-10 1999-02-10 武田薬品工業株式会社 ２―置換クマラン誘導体
US5420289A (en) * 1989-10-27 1995-05-30 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
TW199152B (de) * 1990-11-01 1993-02-01 Takeda Pharm Industry Co Ltd
JP3153335B2 (ja) * 1992-06-05 2001-04-09 興和株式会社 キノリン誘導体又はその塩
JPH09512025A (ja) * 1994-04-23 1997-12-02 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５ｈｔ▲下２ｃ▼および５ｈｔ▲下２ｂ▼アンタゴニストとしての三環式誘導体
US5972935A (en) * 1995-08-11 1999-10-26 Smithkline Beecham P.L.C. Biphenyl(thio)amide and bipennylethan(thi) one derivatives, their preparation and their use as 5-HT1D receptor antagonists
US6147089A (en) * 1998-09-17 2000-11-14 Pfizer Inc. Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines

Also Published As

Publication number Publication date
EP1211253B1 (de) 2004-10-13
EP1211253A1 (de) 2002-06-05
CA2382413A1 (en) 2001-03-01
WO2001014384A1 (fr) 2001-03-01
DE60014936T2 (de) 2005-10-13
ATE279191T1 (de) 2004-10-15
EP1211253A4 (de) 2003-03-26
US6872718B1 (en) 2005-03-29
AU6594900A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
ATE282592T1 (de) 2-oxo-1-pyrrolidinderivate, verfahren zu ihrer herstellung und ihre verwendung
NZ330656A (en) Tricyclic compounds, their production and use
FI982436A (fi) Kondensoituneet heterosykliset yhdisteet
DK1008592T3 (da) Cykliske amidderivater, som inhiberer cathepsin K
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP1020452A4 (de) Benzimidazolderivate
WO2003059900A1 (fr) Derives de coumarine, leur procede de production et d'utilisation
DE69924132D1 (de) Aromatische aminderivate, verfahren zu ihrer herstellung und mittel, die diese enthalten
FI940229A (fi) Trisykliset kondensoituneet heterosykliset yhdisteet, niiden valmistus ja käyttö
DE60014936D1 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
DE69329084D1 (de) Benzoxazepin-Derivate als Cholinesterase-Inhibitoren
ATE383353T1 (de) Verfahren zur herstellung von 2-alkyl-3- aminothiophen derivate und 3-aminothiophen derivate
ATE286050T1 (de) Heterozyclische oder benzol derivate von liponsäure, deren herstellung und deren verwendung als heilmittel
ATE293628T1 (de) Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel
DE60130916D1 (de) Neue beta-lactamverbindungen und verfahren zu deren herstellung
ATE286058T1 (de) Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
ATE170188T1 (de) 2'-desoxy-5-fluoruridin, pharmazeutisch anwendbare salze davon, verfahren zu ihrer herstellung und antitumormedikament
ATE315561T1 (de) Carbamatderivate, verfahren zu deren herstellung und deren verwendung
KR970001326A (ko) 2-나프타미드 유도체의 제조 방법 및 2-나프타미드 유도체 제조용 화합물
CA2181570A1 (en) Metalloproteinase inhibitors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition